access

News

The chairs of six UK parliamentary committees have asked the National Audit Office to investigate the UK-US pharma deal and its impact on the NHS.

News

Pharma groups have held back from submitting around a third of their new medicines for reimbursement in Switzerland, impeding patient access.

News

A series of pilot schemes set up by the UK in partnership with the pharma industry will test ways to get new medicines to patients more quickly.

Oncology

The gap between what CAR-T can do and who can actually get it is the defining challenge of this field right now.

Oncology

National Cancer Survivors’ Day highlighted decades of progress against cancer, but oncology faces a new challenge.

News

Trade organisation EFPIA says disparities in access to new medicines in Europe may be exacerbated by the US's Most-Favoured Nation (MFN) policy.